HomeOpen Access NewsClinical Trials

Clinical Trials

10-Year NHS Health Plan delivers major boost to UK clinical trials

The government has unveiled a transformative initiative that will empower millions of NHS patients to find and join clinical trials via the NIHR’s “Be Part of Research” portal within the NHS App.

Scientists develop Omicron variant vaccine against COVID

MedUni Vienna delivers promising data to the Omicron variant vaccine which could protect people against all known variants of the SARS-CoV-2 virus.

Scientists create non-hormonal male birth control 

Scientists made progress on the implementation of male birth control, which could someday split contraceptive responsibility between all genders.

TheraVision: An oncolytic virus platform technology for a personalised virus-immunotherapy

Prof Dr Susanne M Bailer, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, explains the possibilities of an oncolytic virus platform technology.

Clinical trials begin for three mRNA HIV vaccines

The National Institute of Allergy and Infectious Diseases (NIAID) has launched Phase 1 clinical trials for three mRNA HIV vaccines.

Real-world evidence set to turbo boost personalised healthcare

Richard Armstrong, head of registries at NEC Software Solutions UK, puts real-world evidence under the microscope and examines how, as our population ages it has the power to speed up medical interventions at scale.

New potential therapy for aggressive bladder cancer

Led by Yale Cancer Center, new research shows that enfortumab vedotin is an effective alternative for patients with muscle-invasive bladder cancer (MIBC)

Scientists discover new treatment to fight pancreatic cancer

The potential pancreatic cancer treatment combines an ultrasound and immunotherapy method, with substantial "anti-cancer" benefits in lab mice.

New gene-silencing drug could help with ALS

New research suggests that in suppressing a mutated ALS gene, it may be possible to delay to onset of symptoms.

Early detection of pancreatic cancer – The EUROPAC Research Trial

Dr Deborah Lee, Dr Fox Online Pharmacy, tells us all about the European pancreatic cancer early detection trial (EUROPAC).

Osteogenesis imperfecta – what we need to know

Frost & Sullivan’s TechCasting Group, places the spotlight on osteogenesis imperfecta – toward future targeted, more effective therapy.

Proving the effectiveness of digital health technologies

Professor Freimut Schliess, Director of Science & Innovation, at the Profil Institut für Stoffwechselforschung GmbH, illustrates how dissipating initial scepticism of digital health technologies makes for a thrilling challenge for regulators, manufacturers and clinical researchers alike.

Merck says “COVID pill” can decrease risk of death by 50%

Pharmaceutical company, Merck, have a "COVID pill" at Phase 3 clinical trial - which seems to decrease risk of death by 50%.

NIH funds menstrual cycle and COVID vaccine research

McLean Hospital’s Clinical and Translational Pain Research Laboratory is one of five institutions splitting a $1.67 million NIH grant - the research will examine any links between the menstrual cycle and the COVID vaccine.

What is Osteogenesis Imperfecta (OI)?

Patricia Osborne, Chief Executive of the Brittle Bone Society, tells us what we need to know about Osteogenesis Imperfecta.

Moderna create vaccine trial for children aged 6 months and over

Moderna are enrolling roughly 13,275 participants in their vaccine trial for children - with the participants aged between six months to 12 years.

Study with one million vaccinated people finds AstraZeneca is safe

The study, pre-printed in The Lancet, found that blood clots were far more common in people with COVID-19 than people vaccinated with AstraZeneca.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders